Reply to the letter to the editor: genetic influence on visual outcomes of polypoidal choroidal vasculopathy

被引：0
|
作者：
Hata, Masayuki [1 ,2 ]
Tsujikawa, Akitaka [1 ,2 ]
Yoshimura, Nagahisa [1 ,2 ]
机构：
[1] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan
[2] Kagawa Univ, Fac Med, Dept Ophthalmol, 1750-1 Ikenobe,Miki Cho, Kagawa 7610793, Japan
来源：
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2016年 / 254卷 / 05期
关键词：
Optical Coherence Tomography; Ranibizumab; Fluorescein Angiography; Visual Outcome; Indocyanine Green;
D O I：
10.1007/s00417-015-3163-3
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：1021 / 1022
页数：2
相关论文
共 50 条
  • [11] Author reply to comment on photodynamic therapy and polypoidal choroidal vasculopathy
    Williams, Gwyn Samuel
    Anderson, Luke
    Eddyshaw, David J.
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2014, 62 (11) : 1108 - 1108
  • [12] Association of Lesion Size and Visual Prognosis to Polypoidal Choroidal Vasculopathy
    Tsujikawa, Akitaka
    Ojima, Yumiko
    Yamashiro, Kenji
    Nakata, Isao
    Ooto, Sotaro
    Tamura, Hiroshi
    Nakanishi, Hideo
    Hayashi, Hisako
    Otani, Atsushi
    Yoshimura, Nagahisa
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2011, 151 (06) : 961 - 972
  • [13] Choroidal structure as a biomarker for visual acuity in intravitreal aflibercept therapy for polypoidal choroidal vasculopathy
    Asano, Shotaro
    Azuma, Keiko
    Shimizu, Kimiko
    Yamamoto, Risako
    Lee, Jinhee
    Murata, Hiroshi
    Inoue, Tatsuya
    Asaoka, Ryo
    Obata, Ryo
    PLOS ONE, 2018, 13 (05):
  • [14] GENETIC FACTORS ASSOCIATED WITH CHOROIDAL VASCULAR HYPERPERMEABILITY AND SUBFOVEAL CHOROIDAL THICKNESS IN POLYPOIDAL CHOROIDAL VASCULOPATHY
    Yoneyama, Seigo
    Sakurada, Yoichi
    Kikushima, Wataru
    Sugiyama, Atsushi
    Tanabe, Naohiko
    Mabuchi, Fumihiko
    Kubota, Takeo
    Iijima, Hiroyuki
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (08): : 1535 - 1541
  • [15] Exploring the Ability of Novel Choroidal Biomarkers in Predicting Treatment Outcomes of Polypoidal Choroidal Vasculopathy
    Zhang, Yue
    Wang, Jianing
    Liu, Jing
    Song, Shuang
    Gu, Xiaoya
    Yu, Xiaobing
    OPHTHALMIC RESEARCH, 2024, 67 (01) : 573 - 583
  • [16] Three-year visual outcomes of intravitreal ranibizumab with or without photodynamic therapy for polypoidal choroidal vasculopathy
    Sakai, Tsutomu
    Okano, Kiichiro
    Kohno, Hideo
    Tsuneoka, Hiroshi
    ACTA OPHTHALMOLOGICA, 2016, 94 (08) : E765 - E771
  • [17] One year outcomes of eyes with polypoidal choroidal vasculopathy with=20/40 visual acuity treated with anti-vascular endothelial growth factor agents
    Singh, Sumit R.
    Goud, Nallamasa R.
    Goud, Abhilash
    Sahoo, Niroj K.
    Narayanan, Raja
    Chhablani, Jay
    SAUDI JOURNAL OF OPHTHALMOLOGY, 2021, 35 (02) : 84 - 87
  • [18] Fluid Biomarkers in Optical Coherence Tomography for Visual Outcome in Polypoidal Choroidal Vasculopathy
    Ma, I-Hsin
    Lai, Tso-Ting
    Yang, Chang-Hao
    Ho, Tzyy-Chang
    Yang, Chung-May
    Hsieh, Yi-Ting
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (06):
  • [19] Choroidal morphology and short-term outcomes of combination photodynamic therapy in polypoidal choroidal vasculopathy
    Baek, Jiwon
    Lee, Jae Hyung
    Jeon, Sohee
    Lee, Won Ki
    EYE, 2019, 33 (03) : 419 - 427
  • [20] Two-year outcomes of intravitreal conbercept therapy for polypoidal choroidal vasculopathy
    Liu, Yang
    Guo, Jingli
    Tang, Wenyi
    Xu, Gezhi
    Liu, Wei
    BMC OPHTHALMOLOGY, 2024, 24 (01)
12345